Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Vomiting 3Pain 3Nausea 3Neoplasms 2Taste Disorders 1Parasomnias 1Pancreatic Neoplasms 1Olfaction Disorders 1Cancer Pain 1Breast Neoplasms 1Brain Neoplasms 1Anxiety Disorders 1Anorexia 1

Interventions

Megestrol Acetate 4Mirtazapine 2Infliximab 2Thalidomide 1Surveys and Questionnaires 1Sugars 1Radiotherapy 1Palonosetron 1Olanzapine 1Modafinil 1Minocycline 1Melatonin 1Megestrol 1Gemcitabine 1Etanercept 1Eicosapentaenoic Acid 1Dronabinol 1Docetaxel 1Creatine 1Aromatherapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Anorexia × Dronabinol × Clear all
NCT00316563 2010-02-09

Orexigenic Therapy With Delta-9-tetrahydrocannabinol in Advanced Cancer Patients With Chemosensory Abnormalities - a Pilot Study

AHS Cancer Control Alberta

Phase 2 Completed
80 enrolled

Anorexia, Olfaction Disorders, Neoplasms, Taste Disorders

Data powered by HemOnc (CC BY 4.0) Colophon âš¡